PBIGF (Paradigm Biopharmaceuticals) FFO


PBIGF Paradigm Biopharmaceuticals Ltd PBIGF
18 GF Score
Price $0.13
! 5 Warning Signs
View Full Analysis

What is Paradigm Biopharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

PBIGF
18GF Score
Paradigm Biopharmaceuticals Ltd PBIGF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paradigm Biopharmaceuticals Business Description

Other Exchanges P86:GermanyPAR:Australia
Address 500 Collins Street, Level 15, Melbourne, VIC, AUS, 3000
Paradigm Biopharmaceuticals Ltd is a late-stage clinical development company engaged in the research and development of therapeutic products for human use in Australia. The firm is engaged in developing injectable pentosan polysulfate sodium (iPPS) for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, aging, degenerative disease, infection, or genetic predisposition. The company has registered the trademarks Zilosul and Rhinosul for the commercialization of iPPS.
18GF Score

Get the complete analysis for PBIGF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price